Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1326 ARTÍCULOS , VIENDO DEL 1036 AL 1050

Why pleiotropic interventions are needed for Alzheimer's disease

Frautschy SA, Cole GM.

Mol Neurobiol. 2010 Jun;41(2-3):392-409. doi: 10.1007/s12035-010-8137-1. Epub 2010 May 2.

Why women have more Alzheimer's disease than men: gender and mitochondrial toxicity of amyloid-beta peptide

Viña J, Lloret A.

J Alzheimers Dis. 2010;20 Suppl 2:S527-33. doi: 10.3233/JAD-2010-100501.

NIH state-of-the-science conference statement: Preventing Alzheimer's disease and cognitive decline

Daviglus ML, Bell CC, Berrettini W, Bowen PE, Connolly ES Jr, Cox NJ, Dunbar-Jacob JM, Granieri EC, Hunt G, McGarry K, Patel D, Potosky AL, Sanders-Bush E, Silberberg D, Trevisan M.

NIH Consens State Sci Statements. 2010 Apr 28;27(4):1-30.

[Sleep and episodic memory: a review of the literature in young healthy subjects and potential links between sleep changes and memory impairment observed during aging and Alzheimer's disease]

Rauchs G, Harand C, Bertran F, Desgranges B, Eustache F.

Rev Neurol (Paris). 2010 Nov;166(11):873-81. doi: 10.1016/j.neurol.2010.03.021. Epub 2010 May 5.

[Variant Creutzfeld-Jakob disease (vCJD) : Epidemiology and prevention from human to human secondary transmission]

Beekes M.

Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2010 Jun;53(6):597-605. doi: 10.1007/s00103-010-1070-7.

Music as a memory enhancer in patients with Alzheimer's disease

Simmons-Stern NR, Budson AE, Ally BA.

Neuropsychologia. 2010 Aug;48(10):3164-7. doi: 10.1016/j.neuropsychologia.2010.04.033. Epub 2010 May 7.

Anesthetic sevoflurane causes neurotoxicity differently in neonatal naïve and Alzheimer disease transgenic mice

Lu Y, Wu X, Dong Y, Xu Z, Zhang Y, Xie Z.

Anesthesiology. 2010 Jun;112(6):1404-16. doi: 10.1097/ALN.0b013e3181d94de1.

Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy

Semenov E, Tanden R, Chernev I.

Am J Phys Med Rehabil. 2010 Dec;89(12):1043-4. doi: 10.1097/PHM.0b013e3181ddd3a2.

Insulin resistance, diabetes and cognitive function: consequences for preventative strategies

Bourdel-Marchasson I, Lapre E, Laksir H, Puget E.

Diabetes Metab. 2010 Jun;36(3):173-81. doi: 10.1016/j.diabet.2010.03.001. Epub 2010 May 15.

The arsenic exposure hypothesis for Alzheimer disease

Gong G, OʼBryant SE.

Alzheimer Dis Assoc Disord. 2010 Oct-Dec;24(4):311-6. doi: 10.1097/WAD.0b013e3181d71bc7.

Asymmetric TDP-43 distribution in primary progressive aphasia with progranulin mutation

Gliebus G, Bigio EH, Gasho K, Mishra M, Caplan D, Mesulam MM, Geula C.

Neurology. 2010 May 18;74(20):1607-10. doi: 10.1212/WNL.0b013e3181df0a1b.

Evaluation of an assessment battery for estimating dementia caregiver needs for health and social care services

Marziali E, McCleary L, Streiner DL.

Am J Alzheimers Dis Other Demen. 2010 Aug;25(5):446-54. doi: 10.1177/1533317510370958. Epub 2010 May 19.

Cognition, language, and clinical pathological features of non-Alzheimer's dementias: an overview

Reilly J, Rodriguez AD, Lamy M, Neils-Strunjas J.

J Commun Disord. 2010 Sep-Oct;43(5):438-52. doi: 10.1016/j.jcomdis.2010.04.011. Epub 2010 May 6.

Association of depression with subsequent mortality, cardiovascular morbidity and incident dementia in people aged 80 and over and suffering from hypertension. Data from the Hypertension in the Very Elderly Trial (HYVET)

Peters R, Pinto E, Beckett N, Swift C, Potter J, McCormack T, Nunes M, Grimley-Evans J, Fletcher A, Bulpitt C.

Age Ageing. 2010 Jul;39(4):439-45. doi: 10.1093/ageing/afq042. Epub 2010 May 23.

Dementia risk prediction in the population: are screening models accurate?

Stephan BC, Kurth T, Matthews FE, Brayne C, Dufouil C.

Nat Rev Neurol. 2010 Jun;6(6):318-26. doi: 10.1038/nrneurol.2010.54. Epub 2010 May 25.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias